Enucleation for benign or borderline tumors of the pancreas

• Verfasst von: Ei, Shigenori [VerfasserIn]
• Verfasst von: Mihaljevic, André Leopold [VerfasserIn]
• Verfasst von: Kulu, Yakup [VerfasserIn]
• Verfasst von: Kaiser, Jörg [VerfasserIn]
• Verfasst von: Hinz, Ulf [VerfasserIn]
• Verfasst von: Büchler, Markus W. [VerfasserIn]
• Verfasst von: Hackert, Thilo [VerfasserIn]
• Titel: Enucleation for benign or borderline tumors of the pancreas
• Titelzusatz: comparing open and minimally invasive surgery
• Verf.angabe: Shigenori Ei, André L. Mihaljevic, Yakup Kulu, Joerg Kaiser, Ulf Hinz, Markus W. Büchler, Thilo Hackert
• Jahr: 2021
• Umfang: 6 S.
• Fussnoten: Available online 18 October 2020 ; Gesehen am 09.07.2021
• Titel Quelle: Enthalten in: HPB
• Ort Quelle: [London] : Elsevier, 1999
• Jahr Quelle: 2021
• Band/Heft Quelle: 23(2021), 6 vom: Juni, Seite 921-926
• ISSN Quelle: 1477-2574
• DOI: doi:10.1016/j.hpb.2020.10.001
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 176259661X

Abstract

Background - The feasibility and safety of minimally invasive enucleation (ME) for benign or borderline pancreatic tumors is still unclear. The aim of this study was to compare outcomes between ME and open enucleation (OE). - Methods - All patients undergoing pancreatic enucleation between October 2001 and January 2020 were analyzed from a prospective database. Consecutive patients undergoing ME were compared with patients undergoing OE in a matched-pair analysis (1:2). - Results - Of 358 patients, undergoing enucleation, 120 matched patients (ME n = 40, OE n = 80) were included. Patients undergoing ME had less blood loss (median 50 vs. 100 ml, P = 0.025) and had a higher proportion of patients discharged by 7 days, than patients undergoing OE (38% vs. 18%, P = 0.016). The rates of clinically relevant postoperative pancreatic fistula (POPF) and major complications (Clavien grade ≥ 3) were similar between both groups. Risk factor analysis for POPF B/C showed no significant parameters associated with POPF, including tumor size and proximity to the main pancreatic duct. - Conclusion - Compared with conventional OE, ME reduces the amount of bleeding and allows earlier postoperative discharge, without increasing the incidence of major complications. Thus, minimally invasive enucleation should be considered for benign tumors of the pancreas when technically and oncologically feasible.